Monitor future 13G/H filings for further reductions below 5% or conversion to 13D if the fund's intent changes. The 4.2% stake is below the 5% threshold, so further decreases may not require immediate disclosure.
Price Chart
Executive Summary
T. Rowe Price Investment Management, Inc. filed an amendment to its Schedule 13G, disclosing a 4.2% passive stake in Bicara Therapeutics Inc. as of September 30, 2026. The filing shows a slight decrease from a prior undisclosed level, but the stake remains above 5%? No — the filing states 4.2%, which is below 5%, indicating the fund may be reducing its position. This is a routine passive disclosure with no material change in investment intent.
Key Financial Metrics
Key Facts
- T. Rowe Price Investment Management, Inc. filed a Schedule 13G/A for Bicara Therapeutics Inc.
- Beneficial ownership reported as 2,804,772 shares of common stock, representing 4.2% of shares outstanding.
- The filing is dated as of September 30, 2026, and was filed on October 7, 2026.
- The stake is below 5%, suggesting a passive investment with no activist intent.
- The filing certifies the securities were acquired in the ordinary course of business and not to influence control.
Financial Impact
No financial impact — passive stake disclosure with no material change in ownership or intent.
Risk Factors
- Potential further selling by T. Rowe Price could pressure the stock if the fund continues to reduce its position.
- Low trading volume in BCAX could amplify any selling impact.
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| SC 13G/A Filing (Primary) | 0001897612-26-000635 |
| Document: 0001897612-26-000635-index.html | 0001897612-26-000635 |
| Document: 0001897612-26-000635.txt | 0001897612-26-000635 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 7, 2026 19d ago | SC 13G/A | $16.42 | awaiting T+20 | — | $16.89 (+2.86%) |
Oct 5, 2026 21d ago | Press Release | $17.29 | awaiting T+20 | — | $16.89 (−2.31%) |
Sep 22, 2026 4w ago | Institutional Cluster | $22.78 $18.35 | ▼ −19.45% | ▼ −18.89% | $16.89 (−25.86%) |
Aug 25, 2026 8w ago | 8-K | $24.73 $19.78 | ▼ −20.02% | ▼ −20.24% | $16.89 (−31.70%) |
Aug 14, 2026 10w ago | Press Release | $24.28 $23.20 | ▼ −4.45% | ▼ −2.46% | $16.89 (−30.44%) |
Aug 12, 2026 10w ago | Insider Cluster | $23.63 $22.81 | ▼ −3.47% | ▼ −1.72% | $16.89 (−28.52%) |
Aug 12, 2026 10w ago | Insider Cluster | $23.63 $22.81 | ▼ −3.47% | ▼ −1.72% | $16.89 (−28.52%) |
Aug 11, 2026 10w ago | 8-K | $23.76 $23.64 | ▼ −0.51% | ▲ +0.55% | $16.89 (−28.91%) |
Aug 11, 2026 10w ago | Press Release | $23.76 $23.64 | ▼ −0.51% | ▲ +0.55% | $16.89 (−28.91%) |
Jul 14, 2026 14w ago | Insider Cluster | $28.12 $24.63 | ▼ −12.40% | ▼ −14.74% | $16.89 (−39.93%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers